Published in Malaria Weekly, March 12th, 2012
"IgG1, IgG2, IgG3 and IgG4 could not be used to clearly distinguish PCM patients from those in the NC group using either antigen....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Malaria Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.